What is thymosin alpha 1?
Thymosin Alpha-1, also written thymosin alpha 1, Tα1 or TA1, is a 28-amino-acid peptide with an acetylated N-terminus. The original isolation and sequence-analysis study characterized it from calf thymus fraction 5 in 1977.
It is a different molecule from thymosin beta-4 and from materials sold as TB-500. Similar names do not make their sequences, research pathways or analytical specifications interchangeable.
Dendritic-cell and immune signaling research
A 2004 primary study examined dendritic-cell activation through Toll-like receptor 9 and MyD88-dependent pathways. These experiments connect thymosin alpha 1 to innate immune signaling and subsequent immune-cell responses in the systems studied.
Such pathway observations do not establish a universal immune response or a benefit in people. Model, cell type, exposure conditions and assay endpoints are essential parts of interpreting the result.
Published-research summary and limitations
The literature includes biochemical characterization, cell and animal experiments, and clinical investigations in specific infectious-disease and cancer settings. A 2020 review summarizes this heterogeneous evidence; it is a secondary source, not a new clinical experiment.
Clinical findings must be read against the actual study population, comparator, formulation and endpoint rather than treated as a general claim about immune health. Novanta’s laboratory material is not a clinical formulation, and this reference provides no treatment, dosing or human-use recommendation.
Thymosin Alpha-1 analytical testing and COA
The posted ILS Laboratories certificate COA-2026-956327 identifies the submitted sample as Thymosin Alpha-1 10mg, lot NR5AMNO-0021, and reports 99.53% RP-HPLC area-normalized peptide purity. The unusual lot prefix is reproduced exactly as printed on the report rather than renamed or inferred from the compound.
The report describes identity assessment by chromatographic retention-time comparison with a reference standard. That is not peptide mass-spectrometric confirmation; ICP-MS elemental-impurity testing is a different analysis and must not be described as peptide sequence identification.
An HPLC purity percentage is a method-specific result for the submitted sample, not proof of sterility, biological activity or clinical safety. The certificate header lists an analysis date of July 31, 2026, while its notes and issuance show August 26, 2026; this discrepancy requires laboratory clarification and neither date is presented here as a newly verified review date.
Descriptions of mass spectrometry above explain an analytical method, not testing performed on Novanta material. The currently posted Novanta reports do not include peptide mass-spectrometry results. Read the matching lot certificate for the identity method actually reported; ICP-MS heavy-metals screening is not peptide molecular-identity testing.
Thymosin Alpha-1 stability and handling
No universal shelf life or post-reconstitution interval is asserted for thymosin alpha 1. Sequence, formulation, pH, concentration, container and temperature should be documented and evaluated using a stability-indicating analytical method.
Keep sealed lyophilized research material protected from moisture and light according to its lot documentation. Handling directions from a clinical formulation cannot be transferred automatically to a different laboratory material.
Reconstitution and solution-state variables
Research water reconstitution is not a universal protocol. Peptide sequence, charge, concentration, pH, ionic strength, excipients, container and temperature can each change solubility and solution stability. Researchers should use compound- and protocol-specific controls rather than transfer a preparation method from another molecule.
The Research Water reference explains bacteriostatic and sterile water specifications, contamination controls and post-reconstitution stability limits. The Reconstitution Chemistry article and calculator provide additional laboratory context; neither supplies dosing or human-use instructions.
Novanta lot documentation
- Laboratory
- ILS Laboratories
- Lot
- NR5AMNO-0021
- HPLC result
- 99.53%
- Analysis date
- 07/31/2026
Research material
Product availability, vial size and purchasing information are kept separate from this scientific reference.
View research materialReferences
- 01Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptideProceedings of the National Academy of Sciences — primary characterization study · 1977
- 02Thymosin alpha1 activates dendritic cells via Toll-like receptor 9 and MyD88-dependent pathwaysBlood — primary mechanistic study · 2004
- 03Thymosin alpha 1: A comprehensive review of the literatureWorld Journal of Virology — literature review · 2020
Research questions
- Is there one reconstitution protocol for Thymosin Alpha-1?
- No. Thymosin Alpha-1 solution behavior depends on formulation, concentration, pH, container, temperature and the experimental system. A protocol-specific stability study is more reliable than a generalized interval.
- What does a purity result establish for Thymosin Alpha-1?
- Chromatographic purity describes the measured sample composition under the reported method. It does not establish sterility, biological activity, clinical safety or suitability for human use.
- What is thymosin alpha 1 peptide?
- Thymosin alpha 1 (Tα1 or TA1) is a 28-amino-acid peptide with an acetylated N-terminus, originally characterized from thymus material. Its immune-signaling literature is distinct from the research on thymosin beta-4.
- Is Thymosin Alpha-1 the same as TB-500?
- No. Thymosin Alpha-1 and thymosin beta-4 are different peptides. TB-500 is a research-market name associated with thymosin beta-4 sequences or fragments, not thymosin alpha 1.
- Is a Thymosin Alpha-1 COA available?
- Yes. The posted certificate identifies Thymosin Alpha-1 10mg, lot NR5AMNO-0021, with 99.53% RP-HPLC purity for the submitted sample. The report's date discrepancy is noted in the testing section; the result does not establish a clinical outcome.
Related Research Library articles
Peptide Science
How Signaling Peptides Work
Most research peptides are messengers, not building material. Here is the receptor-level logic behind why a short sequence can produce a large downstream effect.
Handling & Storage
Peptide Storage and Handling for Research Labs
Temperature, light, moisture and freeze–thaw cycles. A practical storage protocol for lyophilized and reconstituted material.
Research-use boundary
For laboratory and research use only. Not for human or veterinary consumption. This page summarizes published research and does not provide medical advice, dosing guidance, or evidence that preclinical observations translate to people.